Live Cell Encapsulation Companies

Latest Live Cell Encapsulation Companies Update

• Nov 2023 Leading provider of cell-free DNA testing worldwide, Natera, Inc., announced that it has partnered with Merck, referred to as MSD outside of the US and Canada, to use Natera's real-world database (RWD) for cancer research advancement. De-identified clinical and genomic data from over 100,000 cancer patients in both early and late stages who underwent testing with SignateraTM, the company's customized and tumor-informed molecular residual disease (MRD) test, are included in Natera's oncology RWD. For most patients, longitudinal monitoring data is accessible, offering an objective gauge of the molecular response to therapy and linked to a multimodal database encompassing imaging, genetic profiling, and clinical outcomes. Pharmaceutical companies can strategically utilize Natera's RWD to accelerate their drug development projects in early-stage and metastatic scenarios.

• Jan 2023 According to a press release from Roanoke Regional Partnership, Balchem Corporation, a specialty nutrition and health ingredient manufacturer, is starting a $5 million development project at its Covington, VA production plant for animal nutrition and health nutrients. The money will be utilized to double the site's present nutritional capacity. The initiative will result in the addition of six new positions to the facility's workforce.

• Lycored


• Blacktrace Holdings Ltd.


• Living Cell Technologies


• Reed Pacific Pty Limited


• MiKroCaps


• Neurotech Holdings LLC


• Sernova Corporation


• Encapsys LLC


• Sigilon TherapeuticsInc.